Effects of interfering and influencing factors on the analyses of p105 (c-erbB-2/HER-2) oncoprotein fragment in serum

Anticancer Research

Volumn 17, Issue 4 B, 1997, Pages 3125-3127

  Mielke, Stephan ^a   Meden, Harald ^a   Raab, Titus ^a   Wuttke, Wolfgang ^a   Kuhn, Walther ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cycle menopause; Menstrual; Normal; p105; Range; Serum

Indexed keywords

MONOCLONAL ANTIBODY; ONCOPROTEIN;

ADULT; AGED; BLOOD STORAGE; BREAST CANCER; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; ONCOGENE C ERB; OVARY CANCER; POSTMENOPAUSE; PREGNANCY; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN; REPRODUCIBILITY; SERUM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MICE; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; RECEPTOR, ERBB-2;

EID: 0030865749     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-181, 1987.
2. Meden H, Marx D, Rath W, Kron M, Fattahi A, Hinney B, Kuhn W, Schauer A: Overexpression of the oncogene c-erbB-2 in primary ovarian cancer: evaluation of the prognostic value in a Cox proprtional hazards multiple regression. Int J Gynecol Pathol 13: 45-53, 1994.
3. Carney WP, Hamer PJ, Petit D, Retos C, Greene R, Zabrecky JR, McKenzie S, Hayes D, Kufe D, De Lellis R, Naber S, Wolfe H: Detection and quantitation of the human neu oncoprotein. In: Journal of Tumormarker Oncology, Volume 6 (Liebert MA, eds). 1991, pp 53-72.
4. Kynast B, Binder L, Marx D, Zoll B, Schmoll HJ, Oellerich M, Schauer A: Determination of a fragment of the c-erbB-2 translational product p185 in serum of breast cancer patients. J Cancer Res Clin Oncol 119: 249-252, 1993.
5. Meden H, Marx D, Fattahi A, Rath W, Kron M, Wuttke W, Schauer A, Kuhn W: Elevated serum levels of a c-erbB-2 oncogene product in ovarian cancer patients and in pregnancy. J Cancer Res Clin Oncol 120: 378-381, 1994.
6. Meden H, Marx D, Raab T, Mielke S, Kron M, Wuttke W, Schauer A, Kuhn W: Detection and quantitation of a p185 (c-erbB-2) oncoprotein fragment: first experience with a new polyclonal ELISA in ovarian cancer patients and controls. In: Pathology research and practice, Volume 191/3 (Schaefer HE, eds). Jena, Gustav Fischer Verlag, 1995, 222.
7. Dati C, Antoniotti S, Taverna D, Perroteau I, De-Bortoli M: Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells. Oncogene 5: 1001-6, 1990.